Humoral activity of cord blood-derived stem/progenitor cells: Implications for stem cell-based adjuvant therapy of neurodegenerative disorders

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Paczkowska, Edyta ^a   Kaczyńska, Katarzyna ^a   Pius Sadowska, Ewa ^a   Rogińska, Dorota ^a   Kawa, Miłosz ^a   Ustianowski, Przemysław ^a   Safranow, Krzysztof ^a   Celewicz, Zbigniew ^a   Machaliński, Bogusław ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD133 ANTIGEN; CD34 ANTIGEN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR P75; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN CDNF; PROTEIN MANF; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE C; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; NEUROBLASTOMA CELL; NEUROPROTECTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; STEADY STATE; STEM CELL; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD DERIVED STEM CELL; WESTERN BLOTTING;

ANTIGENS, CD34; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; FETAL BLOOD; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; NERVE GROWTH FACTORS; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS;

EID: 84896726407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083833     Document Type: Article

References (61)

1. Harris DT (2008) Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev 4(4): 269-274.
2. Fan CG, Zhang QJ, Tang FW, Han ZB, Wang GS, et al. (2005) Human umbilical cord blood cells express neurotrophic factors. Neurosci Lett 380(3): 322-325.
3. Hau S, Reich DM, Scholz M, Naumann W, Emmrich F, et al. (2008) Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neurosci 9:30.
4. Habich A, Jurga M, Markiewicz I, Lukomska B, Bany-Laszewicz U, et al. (2006) Early appearance of stem/progenitor cells with neural-like characteristics in human cord blood mononuclear fraction cultured in vitro. Exp Hematol 34(7): 914-925.
5. Newman MB, Willing AE, Manresa JJ, Sanberg CD, Sanberg PR (2006) Cytokines produced by cultured human umbilical cord blood (HUCB) cells: Implications for brain repair. Exp Neurol 199(1): 201-208.
6. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, et al. (2008) Transplantation of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly after Complete Transection of the Rat Spinal Cord. PLoS ONE 3(10): e3336.
7. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, et al. (2005) Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14(5): 595-604. (Pubitemid 41780811)
8. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, et al. (2004) Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114(3): 330-338. (Pubitemid 39071605)
9. Newman MB, Willing AE, Manresa JJ, Davis-Sanberg C, Sanberg PR (2005) Stroke-induced migration of human umbilical cord blood cells: Time course and cytokines. Stem Cells Dev 14(5): 576-586. (Pubitemid 41780809)
10. Kim SU, de Vellis J (2009) Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 87(10): 2183-2200.
11. Reich DM, Hau S, Stahl T, Scholz M, Naumann W, et al. (2008) Neuronal hypoxia in vitro: Investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells. BMC Neurosci 9:91.
12. Boltze J, Reich DM, Hau S, Reymann KG, Strassburger M, et al. (2012) Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant 21(4): 723-737.
13. Arien-Zakay H, Lecht S, Bercu MM, Tabakman R, Kohen R, et al. (2009) Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp Neurol 216(1): 83-94.
14. Jiang L, Womble T, Saporta S, Chen N, Sanberg CD, et al. (2010) Human umbilical cord blood cells decrease microglial survival in vitro. Stem Cells Dev 19(2): 221-228.
15. Leonardo CC, Hall AA, Collier LA, Ajmo CT Jr, Willing AE, et al. (2010) Human umbilical cord blood cell therapy blocks the morphological change and recruitment of CD11b-expressing, isolectin-binding proinflammatory cells after middle cerebral artery occlusion. J Neurosci Res 88(6): 1213-1222.
16. Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration. Pharmacol Ther 138(2): 155-175.
17. Lindholm P, Saarma M (2010) Novel CDNF/MANF family of neurotrophic factors. Dev Neurobiol 70(5): 360-371.
18. Sohn J, Selvaraj V, Wakayama K, Orosco L, Lee E, et al. (2012) PEDF is a novel oligodendrogenic morphogen acting on the adult SVZ and corpus callosum. J Neurosci 32(35): 12152-12164.
19. Huang EJ, Reichardt L (2001) Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24: 677-736. (Pubitemid 32695243)
20. Saarma M, Sariola H (1999) Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF). Microsc Res Tech 45(4-5): 292-302. (Pubitemid 29264993)
21. Wei L, Fraser JL, Lu ZY, Hu X, Yu SP (2012) Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis 46(3): 635-645.
22. Rao M, Ahrlund-Richter L, Kaufman DS (2012) Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities. Stem Cells 30(1): 55-60.
23. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, et al. (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98(8): 2396-402.
24. Douglas-Escobar M, Rossignol C, Steindler D, Zheng T, Weiss MD (2012) Neurotrophin-Induced Migration and Neuronal Differentiation of Multipotent Astrocytic Stem Cells In Vitro. PLoS ONE 7(12): e51706.
25. Greenberg ME, Xu B, Lu B, Hempstead BL (2009) New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 29(41): 12764-12767.
26. Guo JS, Zeng YS, Li HB, Huang WL, Liu RY, et al. (2007) Cotransplant of neural stem cells and NT-3 gene modified Schwann cells promote the recovery of transected spinal cord injury. Spinal Cord 45(1): 15-24.
27. Estaquier J, Vallette F, Vayssiere JL, Mignotte B (2012) The mitochondrial pathways of apoptosis. Adv Exp Med Biol 942: 157-83.
28. Brock JH, Rosenzweig ES, Blesch A, Moseanko R, Havton LA, et al. (2010) Local and remote growth factor effects after primate spinal cord injury. J Neurosci 30(29): 9728-9737.
29. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302): 964-967. (Pubitemid 27087709)
30. Goldenberg-Cohen N, Avraham-Lubin BC, Sadikov T, Goldstein RS, Askenasy N (2012) Primitive stem cells derived from bone marrow express glial and neuronal markers and support revascularization in injured retina exposed to ischemic and mechanical damage. Stem Cells Dev 21(9): 1488-1500.
31. Schwarting S, Litwak S, Hao W, Bähr M, Weise J, et al. (2008) Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 39(10): 2867-2875.
32. Pelagiadis I, Relakis K, Kalmanti L, Dimitriou H (2012) CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord blood. Cytotherapy 14(6): 701-706.
33. Flores-Guzman P, Fernandez-Sanchez V, Valencia-Plata I, Arriaga-Pizano L, Alarcon-Santos G, et al. (2013) Comparative in vitro analysis of different hematopoietic cell populations from human cord blood: in search of the best option for clinically oriented ex vivo cell expansion. Transfusion 53(3): 668-678.
34. Servida F, Soligo D, Caneva L, Bertolini F, de Harven E, et al. (1996) Functional and morphological characterization of immunomagnetically selected CD34(+) hematopoietic progenitor cells. Stem Cells 14(4): 430-438. (Pubitemid 26286264)
35. Majdic O, Stöckl J, Pickl WF, Bohuslav J, Strobl H, et al. (1994) Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 83(5): 1226-1234. (Pubitemid 24062845)
36. Dao MA, Arevalo J, Nolta JA (2003) Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood 101(1): 112-118. (Pubitemid 36025896)
37. Paczkowska E, Kucia M, Koziarska D, Halasa M, Safranow K, et al. (2009) Clinical evidence that very small embryonic-like stem cells are mobilized into peripheral blood in patients after stroke. Stroke 40(4): 1237-1244.
38. Forraz N, Pettengell R, McGuckin CP (2004) Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Stem Cells 22(1): 100-108. (Pubitemid 38018786)
39. Chen SH, Chang FM, Tsai YC, Huang KF, Lin CL, et al. (2006) Infusion of human umbilical cord blood cells protect against cerebral ischemia and damage during heatstroke in the rat. Exp Neurol 199(1): 67-76.
40. Stroh A, Boltze J, Sieland K, Hild K, Gutzeit C, et al. (2009) Impact of magnetic labeling on human and mouse stem cells and their long-term magnetic resonance tracking in a rat model of Parkinson disease. Mol Imaging 8(3): 166-178.
41. Zanier ER, Montinaro M, Vigano M, Villa P, Fumagalli S, et al. (2011) Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit Care Med 39(11): 2501-2510.
42. McTigue DM, Horner PJ, Stokes BT, Gage FH (1998) Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 18(14): 5354-5365. (Pubitemid 28311952)
43. Kwon BK, Liu J, Messerer C, Kobayashi NR, McGraw J, et al. (2002) Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury. Proc Natl Acad Sci U S A 99(5): 3246-3251. (Pubitemid 34240617)
44. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, et al. (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189(5): 865-870. (Pubitemid 29189691)
45. Bracci-Laudiero L, Celestino D, Starace G, Antonelli A, Lambiase A, et al. (2003) CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J Neuroimmunol 136(1-2): 130-139. (Pubitemid 36298852)
46. Simone MD, De Santis S, Vigneti E, Papa G, Amadori S, et al. (1999) Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematol Oncol 17(1): 1-10. (Pubitemid 29410396)
47. Sun Y, Jin K, Xie L, Childs J, Mao XO, et al. (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111(12): 1843-1851. (Pubitemid 38057729)
48. Ng YY, van Kessel B, Lokhorst HM, Baert MR, van den Burg CM, et al. (2004) Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity. J Leukoc Biol 75(2): 314-323. (Pubitemid 38174589)
49. Jaatinen T, Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, et al. (2006) Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells 24(3): 631-641. (Pubitemid 44464767)
50. Hemmoranta H, Hautaniemi S, Niemi J, Nicorici D, Laine J, et al. (2006) Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells. Stem Cells Dev 15(6): 839-851. (Pubitemid 46147856)
51. Fumagalli F, Racagni G, Riva MA (2006) The expanding role of BDNF: a therapeutic target for Alzheimer's disease? Pharmacogenomics J 6(1): 8-15. (Pubitemid 43118305)
52. Romero MI, Rangappa N, Garry MG, Smith GM (2001) Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy. J Neurosci 21(21): 8408-8416. (Pubitemid 33051439)
53. Guillin O, Griffon N, Bezard E, Leriche L, Diaz J, et al. (2003) Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. Eur J Pharmacol 480(1-3): 89-95. (Pubitemid 37410363)
54. Fu SY, Gordon T (1997) The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14(1-2): 67-116. (Pubitemid 127720197)
55. Terenghi G (1999) Peripheral nerve regeneration and neurotrophic factors. J Anat 194(Pt 1): 1-14.
56. Lönne M, Lavrentieva A, Walter JG, Kasper C (2013) Analysis of oxygen-dependent cytokine expression in human mesenchymal stem cells derived from umbilical cord. Cell Tissue Res 353(1): 117-122.
57. Bakondi B, Shimada IS, Perry A, Munoz JR, Ylostalo J, et al. (2009) CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Mol Ther 17(11): 1938-47.
58. Cantinieaux D, Quertainmont R, Blacher S, Rossi L, Wanet T, et al. (2013) Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation. PLoS One 8(8): e69515.
59. Salgado AJ, Fraga JS, Mesquita AR, Neves NM, Reis RL, et al. (2010) Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation. Stem Cells Dev 19(7): 1067-74.
60. Yang Z, von Ballmoos MW, Faessler D, Voelzmann J, Ortmann J, et al. (2010) Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 211(1): 103-9.
61. Iso Y, Rao KS, Poole CN, Tarikuz Zaman AK, et al. (2013) Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction. Stem Cell. doi: 10.1002/stem.1546. [Epub ahead of print]